AFR: Genesis Capital invests in AusTrials; clinical trials M&A heats up
The AFR has highlighted our investment in AusTrials, a leading Australian clinical research organisation operating across multiple therapeutic areas.
Clinical research is vital to advancing healthcare, and AusTrials is exceptionally well positioned to grow its impact.
Australia’s clinical research sector continues to play a meaningful role in supporting global trial activity, and AusTrials has established itself as a respected operator within this landscape. Our investment supports the organisation’s objectives to expand its capabilities, strengthen site operations and build deeper partnerships with sponsors.
Entering the clinical research sector aligns with our focus on healthcare businesses with specialised expertise, strong leadership teams and the potential for significant scale. We are pleased to partner with AusTrials as it advances this important area of healthcare.
Read the full AFR article:
https://www.afr.com/street-talk/genesis-capital-invests-in-austrials-clinical-trials-m-and-a-heats-up-20230730-p5dsen